EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische ÜbersichtOpen Access · CC BY 4.0

Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review

Guilherme Lopes de Oliveira Pagotto, Livia Maria Oliveira Dos Santos, Najwa Osman, Caroline Barbalho Lamas, Lucas Fornari Laurindo iD, Karina Torres Pomini, Leila M Guissoni, Enzo Pereira de Lima, Ricardo de Alvares Goulart, Virginia M C Strozze Catharin, Rosa Direito iD, Masaru Tanaka iD und 1 weitere

Antioxidants · 27.05.2024 · 13 (6) · 651

DOI: 10.3390/antiox13060651 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Antioxidants, online erschienen am 27.05.2024. Verfasst von Guilherme Lopes de Oliveira Pagotto und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho, 1001, Marília 17525-902,…. Die Arbeit wurde bisher 41-mal zitiert (Crossref) und nennt 215 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HUN-REN Hungarian Research Network.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a stealthy and progressive neurological disorder that is a leading cause of dementia in the global elderly population, imposing a significant burden on both the elderly and society. Currently, the condition is treated with medications that alleviate symptoms. Nonetheless, these drugs may not consistently produce the desired results and can cause serious side effects. Hence, there is a vigorous pursuit of alternative options to enhance the quality of life for patients. Ginkgo biloba (GB), an herb with historical use in traditional medicine, contains bioactive compounds such as terpenoids (Ginkgolides A, B, and C), polyphenols, organic acids, and flavonoids (quercetin, kaempferol, and isorhamnetin). These compounds are associated with anti-inflammatory, antioxidant, and neuroprotective properties, making them valuable for cognitive health. A systematic search across three databases using specific keywords—GB in AD and dementia—yielded 1702 documents, leading to the selection of 15 clinical trials for synthesis. In eleven studies, GB extract/EGb 761® was shown to improve cognitive function, neuropsychiatric symptoms, and functional abilities in both dementia types. In four studies, however, there were no significant differences between the GB-treated and placebo groups. Significant improvements were observed in scores obtained from the Mini-Mental State Examination (MMSE), Short Cognitive Performance Test (SKT), and Neuropsychiatric Inventory (NPI). While the majority of synthesized clinical trials show that Ginkgo biloba has promising potential for the treatment of these conditions, more research is needed to determine optimal dosages, effective delivery methods, and appropriate pharmaceutical formulations. Furthermore, a thorough assessment of adverse effects, exploration of long-term use implications, and investigation into potential drug interactions are critical aspects that must be carefully evaluated in future studies.

Schlagwörter

Stichwörter der Autor:innen

Alzheimer’s diseaseEGb 761Gingko bilobacognitive dysfunctionflavonoidsterpenoids

Autor:innen und Institutionen

  • Department of Biochemistry and Pharmacology, School of Medicine, University of Marília (UNIMAR), Avenida Higino Muzzi Filho, 1001, Marília 17525-902, SP, Brazil.
  • Department of Gerontology, Universidade Federal de São Carlos, UFSCar, São Carlos 13565-905, SP, Brazil.
  • Department of Biochemistry and Pharmacology, School of Medicine, Faculdade de Medicina de Marília (FAMEMA), Marília 17519-030, SP, Brazil.
  • Postgraduate Program in Structural and Functional Interactions in Rehabilitation, Marília 17525-902, SP, Brazil.
  • Laboratory of Systems Integration Pharmacology, Clinical & Regulatory Science, Research Institute for Medicines (iMed.ULisboa), Faculdade de Farmácia, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portu…
  • Faculty of Pharmacy, Universidade de Lisboa, Av. Prof. Gama Pinto, 1649-003 Lisboa, Portugal.

ORCID-Profile: Lucas Fornari Laurindo, Rosa Direito, Masaru Tanaka, Sandra Maria Barbalho

Förderung

  • HUN-REN Hungarian Research Network

Zitieren

APA

Pagotto, G. L. O., Santos, L. M. O. D., Osman, N., Lamas, C. B., Laurindo, L. F., Pomini, K. T., Guissoni, L. M., Lima, E. P., Goulart, R. A., Catharin, V. M. C. S., Direito, R., Tanaka, M., & Barbalho, S. M. (2024). Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review. Antioxidants, 13(6), 651. https://doi.org/10.3390/antiox13060651

Vancouver

Pagotto GLO, Santos LMOD, Osman N, Lamas CB, Laurindo LF, Pomini KT, et al. Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review. Antioxidants. 2024;13(6):651. doi:10.3390/antiox13060651

BibTeX
@article{Pagotto2024,
  author = {Pagotto, Guilherme Lopes de Oliveira and Santos, Livia Maria Oliveira Dos and Osman, Najwa and Lamas, Caroline Barbalho and Laurindo, Lucas Fornari and Pomini, Karina Torres and Guissoni, Leila M and Lima, Enzo Pereira de and Goulart, Ricardo de Alvares and Catharin, Virginia M C Strozze and Direito, Rosa and Tanaka, Masaru and Barbalho, Sandra Maria},
  title = {Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review},
  journal = {Antioxidants},
  year = {2024},
  volume = {13},
  number = {6},
  pages = {651},
  doi = {10.3390/antiox13060651}
}
Kostenlos starten →